(ZCN) BMO S&P/TSX Capped - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: CA05574G1090 • Canadian Equity

ZCN: Canadian, Equity, Securities, Capped, Composite

The BMO S&P/TSX Capped Composite ETF (Ticker: ZCN) is a Canadian equity exchange-traded fund designed to track the performance of the S&P/TSX Capped Composite Index. This index represents a broad spectrum of Canadian equities, with a cap on individual holdings to ensure diversification and reduce concentration risk. ZCN provides exposure to large-cap Canadian companies across various sectors, including financials, energy, and industrials, making it a core holding for investors seeking domestic market exposure.

From a technical perspective, ZCN is currently trading at $32.74, slightly above its 20-day simple moving average (SMA) of $32.27 but marginally below its 50-day SMA of $32.93. The 200-day SMA stands at $32.18, indicating a modest upward trend over the longer term. The Average True Range (ATR) of 0.68 reflects relatively low volatility.

Fundamentally, ZCN manages assets under management (AUM) of $9,990.87 million CAD, indicating a highly liquid and widely held ETF. Its market-capitalization-weighted approach ensures that larger, more established companies have a greater influence on the funds performance. This structure aligns with the broader Canadian equity market, which is heavily weighted toward financial institutions, energy firms, and industrial companies.

3-Month Forecast: Based on , ZCN is likely to remain range-bound between $31.50 and $33.50 in the near term, with potential for a breakout above $33.50 if the 20-day SMA crosses above the 50-day SMA. Support levels are strong at $31.50, and resistance is moderate at $33.50. If market sentiment improves, ZCN could test $35.00 by the end of the quarter. Conversely, a breakdown below $31.50 could lead to a retest of $30.00. From a perspective, the funds performance will closely align with the health of the Canadian economy. Strength in the financial and energy sectors, which dominate the S&P/TSX Capped Composite Index, will likely drive ZCNs returns. If oil prices remain elevated, energy stocks could outperform, providing a tailwind for the ETF. However, any signs of economic slowing or rising interest rates could lead to a modest correction.

Additional Sources for ZCN ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ZCN ETF Overview

Market Cap in USD 7,244m
Category Canadian Equity
IPO / Inception 2009-05-29

ZCN ETF Ratings

Growth Rating 82.2
Fundamental -
Dividend Rating 63.7
Rel. Strength 4.68
Analysts -
Fair Price Momentum 34.32 CAD
Fair Price DCF -

ZCN Dividends

Dividend Yield 12m 2.81%
Yield on Cost 5y 5.42%
Annual Growth 5y 3.90%
Payout Consistency 98.1%

ZCN Growth Ratios

Growth Correlation 3m -67.3%
Growth Correlation 12m 81.4%
Growth Correlation 5y 89.8%
CAGR 5y 14.37%
CAGR/Max DD 5y 0.88
Sharpe Ratio 12m 1.78
Alpha 7.64
Beta 0.585
Volatility 16.73%
Current Volume 120.9k
Average Volume 20d 188k
What is the price of ZCN stocks?
As of May 02, 2025, the stock is trading at CAD 33.22 with a total of 120,913 shares traded.
Over the past week, the price has changed by +0.36%, over one month by -0.75%, over three months by -1.07% and over the past year by +17.45%.
Is BMO S&P/TSX Capped a good stock to buy?
Yes. Based on ValueRay Analyses, BMO S&P/TSX Capped (TO:ZCN) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 82.23 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZCN as of May 2025 is 34.32. This means that ZCN is currently overvalued and has a potential downside of 3.31%.
Is ZCN a buy, sell or hold?
BMO S&P/TSX Capped has no consensus analysts rating.
What are the forecast for ZCN stock price target?
According to ValueRays Forecast Model, ZCN BMO S&P/TSX Capped will be worth about 38.5 in May 2026. The stock is currently trading at 33.22. This means that the stock has a potential upside of +15.98%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 38.5 16%